HBC Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3K Hold
50
﹤0.01% 151
2024
Q3
$4K Sell
50
-161
-76% -$13.5K ﹤0.01% 145
2024
Q2
$16K Buy
211
+1
+0.5% +$82 0.01% 102
2024
Q1
$16K Buy
210
+3
+1% +$256 0.01% 97
2023
Q4
$17K Buy
207
+2
+1% +$152 0.01% 99
2023
Q3
$16K Hold
205
0.01% 101
2023
Q2
$17K Buy
205
+2
+1% +$172 0.01% 93
2023
Q1
$16K Buy
203
+51
+34% +$4.16K 0.01% 120
2022
Q4
$12K Buy
152
+51
+50% +$4.13K 0.01% 107
2022
Q3
$8K Buy
101
+1
+1% +$90 0.01% 119
2022
Q2
$9K Hold
100
0.01% 125
2022
Q1
$10K Buy
+100
New +$10.6K 0.01% 116

Other funds holding MDT

HBC Financial Services's MDT Position: Q4 2024 in Review

HBC Financial Services held its Medtronic (MDT) position steady in Q4 2024 at 50 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #151.

HBC Financial Services first reported a position in MDT in Q1 2022 and has held it in 12 quarters since. The position peaked at $17K in Q4 2023. 2,130 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • HBC Financial Services held 50 shares of Medtronic worth $3K as of Q4 2024.
  • HBC Financial Services left its Medtronic share count unchanged in Q4 2024.
  • Medtronic made up ﹤0.01% of HBC Financial Services's portfolio in Q4 2024, its #151 holding.
  • HBC Financial Services first reported a position in Medtronic in Q1 2022 and has held it in 12 quarters since.
  • HBC Financial Services's Medtronic position peaked at $17K in Q4 2023.
  • 2,130 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on HBC Financial Services's 13F filing for Q4 2024, filed 16 Jan 2025.